The initiative includes a partnership with Twist Bioscience to integrate watermarking into DNA synthesis screening. Demis Hassabis, CEO of Google DeepMind, stated that biosecurity is a critical challenge for the AI era, and the company is open-sourcing the toolset to allow for further community development. The findings were published in the journal Nature on September 30.
